More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$192037933
EPS
4.12
P/E ratio
15.2
Price to sales
2.61
Dividend yield
--
Beta
0.044377
Previous close
$57.70
Today's open
$57.66
Day's range
$57.66 - $60.21
52 week range
$25.25 - $77
show more
CEO
Richard L. Van Kirk
Employees
181
Headquarters
Irvine, CA
Exchange
NASDAQ Capital Market
Shares outstanding
3233234
Issue type
Common Stock
Healthcare
Medical Equipment & Supplies
5 Medical Dental Supply Stocks to Watch as Industry Prospects Improve
Here, we highlight five medical supplies stocks, MCK, CAH, BDX, MMSI and PDEX, with strong potential that investors should keep on their watchlist amid improving industry prospects.
Zacks Investment Research • Oct 1, 2026

SRK Capital 2026 Semi-Annual Portfolio Update
SRK Fund I, LP increased 26.80% during the first half of the year. In contrast, the S&P 500 and the Russell 2000 returned 10.18% and 22.57%, respectively. ImmuCell delivered a strong first quarter in 2026, underscoring the earnings power and cash-flow potential of its core First Defense franchise after the company's strategic exit from Re-Tain. Since divesting its capital-intensive ammunition manufacturing business in April 2025, Outdoor Holding Company has operated as a pure-play, asset-light marketplace through GunBroker.com.
Seeking Alpha • Sep 21, 2026

New Strong Buy Stocks for September 18th
PGY, OPHC, PDEX, TRV and HMN have been added to the Zacks Rank #1 (Strong Buy) List on September 18th, 2026.
Zacks Investment Research • Sep 18, 2026

Best Momentum Stocks to Buy for September 18th
PDEX, APH and RELY made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 18th, 2026.
Zacks Investment Research • Sep 18, 2026

Pro-Dex, Inc. Announces Fiscal 2026 Fourth Quarter and Full-Year Results
IRVINE, CA / ACCESS Newswire / September 3, 2026 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2026 fourth quarter and full-year ended June 30, 2026.
Accesswire • Sep 3, 2026

Pro-Dex: Still A Buy, But Don't Chase
Pro-Dex reported nice Q1 sales of $19.9 million, which is up 14.6% YoY. Their largest customer contract now runs through December 2028, reducing potential near-term risks in that sense. Also, their APM acquisition gives them more control over their supply chain and brings some potential aerospace/defense optionality.
Seeking Alpha • May 15, 2026

Pro-Dex, Inc. Announces Fiscal 2026 Third Quarter and Nine Month Results
IRVINE, CA / ACCESS Newswire / April 30, 2026 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2026 third quarter ended March 31, 2026.
Accesswire • Apr 30, 2026

Pro-Dex, Inc. Announces Acquisition of Advanced Precision Machining
IRVINE, CA / ACCESS Newswire / February 12, 2026 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced that on February 9, 2026 it completed its acquisition of Advanced Precision Machining LLC, ("APM"), formerly operated as Advanced Precision Machining, Inc., a manufacturing facility located in Costa Mesa, Calif.
Accesswire • Feb 12, 2026

Pro-Dex, Inc. Announces Fiscal 2026 Second Quarter and Six-Month Results
IRVINE, CA / ACCESS Newswire / January 29, 2026 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2026 second quarter ended December 31, 2025.
Accesswire • Jan 29, 2026

Pro-Dex: A Niche Surgical Tools Microcap Trading At A Discount
Pro-Dex manufactures powered surgical instruments for orthopedic, CMF, and thoracic procedures. This means that PDEX effectively combines OEM programs with a smaller catalog of industrial offerings. However, PDEX's revenue today remains highly concentrated. A single customer drives roughly 78% of sales.
Seeking Alpha • Jan 17, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Pro-Dex Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.